focus -WSS

focus

author：focus 2025-09-29 04:11:59 - browse：99

Dr. Laurie Glimcher, CEO of Dana Farber Cancer Institute, opens both arms while talking — coverage from STAT — Laurie Glimcher, CEO of Dana Farber Cancer Institute, is the architect of the biggest shakeup in Boston health care in decades. David L. Ryan/Globe Staff

Dr. Laurie Glimcher learned early on from her father, a prominent physician-researcher, that success in science was built on a basic principle: Big discoveries require big risks.

The younger Glimcher took that advice to heart. In the late 1990s at her Harvard immunology lab, Glimcher and her postdoctoral student began a series of experiments that colleagues deemed “crazy.” But after a year of trial and error, the lab had a eureka moment when it found that white blood cells could be reprogrammed, a seminal discovery that led to new ways to treat cancer.

“Most scientists do good work, but they don’t transform a scientific question,” said Glimcher. “I always felt the only way to do that is to think big and go after something that’s going to be really important.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： FDA early review: GLP

WSS

JPM pitch from hospitals? Revenue streams outside of patient care

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Fauci's latest grilling in Congress: 9 hours, behind closed doors

How I helped Pfizer think through the ethics of Viagra

explore

focus

entertainment

The cancer drug shortage isn’t new — and neither are the solutions

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Hepatitis C has a cure — but many Americans still lack access to it

Allen Institute goes after foundational questions, CEO Costa says

Medicare details structure of new drug price negotiation program

Does Paxlovid work in people vaccinated against Covid

Duchenne breakthrough therapy leaves behind pioneering families

Stories you might have missed in 2023: health, science, medicine

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

It costs an awful lot of money to give away a kidney

hotspot

A controversial new treatment promises to make little people taller

The cancer stories no one wants to hear

2 officers injured in shooting in Orlando, police say

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Profiling embryos to choose those with higher IQs is almost a reality

Arena BioWorks launches in Cambridge to speed drug discovery

hotspot

knowledge

knowledge

hotspot